
|Articles|April 1, 2004
Supplements and Featured Publications
- Newsletter - Inflammation, Metabolic Syndrome, and CV Risk Reduction
- Volume 10
- Issue 1 Metab
Inflammation, Metabolic Syndrome, and CV Risk Reduction
Advertisement
Articles in this issue
about 22 years ago
Traditional CV risk factors: Necessary, but are they sufficient?Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Health Equity & Access Weekly Roundup: June 26, 2026
4
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
5




